Simplex Trading’s Evoke Pharma EVOK Stock Holding History

Simplex Trading’s Portfolio EVOK Stock Details EVOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-22	Closed	-$1K	–	10232
2022 Q1	$1K	Hold	22	–	–	﹤0.01%	10058
2021 Q4	$1K	Buy	22 +12	+120%	+$1.68K	﹤0.01%	10180
2021 Q3	$1K	Hold	10	–	–	﹤0.01%	9632
2021 Q2	$1K	Buy	+10	New	+$2.14K	﹤0.01%	9809
2021 Q1	–	Hold	0	–	–	–	8142
2020 Q4	–	Hold	0	–	-$17K	–	8528
2020 Q3	–	Hold	0	–	–	–	6452

Other funds holding EVOK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Simplex Trading's EVOK Position: Q2 2022 in Review

Simplex Trading sold out of Evoke Pharma (EVOK) in Q2 2022, closing a stake of 21 shares — an estimated $1K sold.

Simplex Trading first reported a position in EVOK in Q4 2021 and held it in 2 quarters. The position peaked at $1K in Q1 2022. 12 funds tracked by Wall St. Rank hold EVOK as of Q2 2022.

Simplex Trading reported no remaining Evoke Pharma position as of Q2 2022 after selling out during the quarter.
Simplex Trading sold 21 Evoke Pharma shares in Q2 2022, an estimated $1K.
Simplex Trading first reported a position in Evoke Pharma in Q4 2021 and held it in 2 quarters.
Simplex Trading's Evoke Pharma position peaked at $1K in Q1 2022.
12 funds tracked by Wall St. Rank held Evoke Pharma as of Q2 2022.

Based on Simplex Trading's 13F filing for Q2 2022, filed 3 Aug 2022.